BACKGROUND: B-type natriuretic peptide (BNP) is released from the cardiac ventricles in
response to increased wall tension in patients with heart failure. The significance of blood …

Objective To explore the predictive value of B-type natriuretic peptide (BNP) for the mortality
of acute myocardial infarction (AMI). Methods Follow-up was made in 264 consecutive …

Background—Circulating levels of B-type natriuretic peptide (BNP), a cardiac hormone,
reflect the severity of cardiac dysfunction. Because the plasma BNP level changes …

Background: An increase in circulating B‐type natriuretic peptide (BNP) is associated with a
poor outcome in patients with acute heart failure. The primary aim of this study was to …

Background B-type natriuretic peptide has been used as a biological marker for prognosis in
patients with acute coronary syndrome (ACS). However, a relation between the quantity of …

Background B-type natriuretic peptide (BNP) is known to be a risk marker following acute
myocardial infarction (MI). More recently, truncated molecular forms of the BNP molecule …

BACKGROUNDS: Elevated B-type natriuretic peptide (BNP) levels show prognostic
significance in patients with non-ST elevation acute coronary syndromes, but the underlying …

Background: The prognostic value of BNP in acute coronary syndrome (ACS) has been
repeatedly assessed, but not completely well established. Literature data for establishing the …

BACKGROUND AND OBJECTIVES: Biochemical markers are useful for the prediction of
cardiac events in patients with acute coronary syndrome (ACS). The N-terminal fragment of …

Background Previous studies showed that blood B-type natriuretic peptide (BNP) level could
predict the prognosis of acute coronary syndromes (ACS). This study investigated the …